The Patent Finder

Intra-Cellular Therapies, Inc.

174 patents currently held · Updated Nov 19, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

36
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Dec 16 to 23, 2026 · next Dec 16
  • 2 fees due Jan 4 to 7, 2027 · next Jan 4
  • 2 fees due Feb 15 to 18, 2027 · next Feb 15
  • 3 fees due Mar 3 to 19, 2027 · next Mar 3
  • 2 fees due Apr 3 to 27, 2027 · next Apr 3
  • 5 fees due May 5 to 28, 2027 · next May 5
  • 4 fees due Jun 1 to 19, 2027 · next Jun 1
  • 2 fees due Jul 16 to 28, 2027 · next Jul 16
  • 1 fee due Aug 9, 2027
    The maintenance fee for Pyrazolo[3,4-D]pyrimidine-4,6(5H,7H)-diones as phosphodiesterase 1 inhibitors (US 9,255,099) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Organic compounds (US 10,597,394) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
  • 2 fees due Oct 16, 2027
  • 2 fees due Nov 14 to 17, 2027 · next Nov 14

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,470,548Diagnosis of depression
In force
 · USPTO record
In forceUSPTO record
US 8,779,139Substituted 2,3,4,4A,5,9b-hexahydro-1H-pyrido[4,3-b]indole Derivatives Synthesis and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,315,504Preparation of 4-((6Br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-(7h)-yl)-1-(4-fluorophenyl)-1-butanone or a Pharmaceutically Acceptable Salt Thereof
In force
 · High confidence
In forceHigh confidence
US 9,751,883Preparation of Certain [((6br,10as)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and Pharmaceutically Acceptable Salts Thereof
In force
 · High confidence
In forceHigh confidence
US 10,221,176PREPARATION OF CERTAIN SUBSTITUTED [((6bR,10aS)-2,3,6b,7,8,9,10,10a-OCTAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALINES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
In force
 · High confidence
In forceHigh confidence
US 10,464,938PHARMACEUTICAL COMPOSITIONS COMPRISING ((6bR,10aS)-1-(4-Fluorophenyl)-4-(3-Methyl-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
In force
 · High confidence
In forceHigh confidence
US 10,597,395PREPARATION OF CERTAIN SUBSTITUTED 1-(4-Fluorophenyl)-4-(2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
In force
 · High confidence
In forceHigh confidence
US 11,066,407PREPARATION OF CERTAIN SUBSTITUTED 1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALINES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
In force
 · High confidence
In forceHigh confidence
US 11,407,751HYDROCHLORIC ACID SALT OF (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-OCTAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALINE
In force
 · High confidence
In forceHigh confidence
US 12,139,490PROCESS FOR PREPARING 1-(4-Fluorophenyl)-4-((6bR,10aS)-3-Methyl-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONE
In force
 · High confidence
In forceHigh confidence
10 of 174 patents shown.
Pro members see all 174.
Pro members: see all 174 patents
Also on record, not counted in the 174: 2 patents in force now held by others · 3 lapsed for an unpaid fee · 4 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

32 pending · 6 abandoned · 28 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited